Hans Netter

3.5k total citations
89 papers, 2.1k citations indexed

About

Hans Netter is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hans Netter has authored 89 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 31 papers in Hepatology and 19 papers in Molecular Biology. Recurrent topics in Hans Netter's work include Hepatitis B Virus Studies (38 papers), Hepatitis C virus research (23 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). Hans Netter is often cited by papers focused on Hepatitis B Virus Studies (38 papers), Hepatitis C virus research (23 papers) and Hepatitis Viruses Studies and Epidemiology (13 papers). Hans Netter collaborates with scholars based in Australia, Germany and United States. Hans Netter's co-authors include Hans H. Guldner, Carin Szostecki, Hans Will, John M. Taylor, Helene Will, Lilly Yuen, Margaret Littlejohn, Eric J. Gowans, Beena Jeevan-Raj and Wai-Ping Woo and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Hans Netter

86 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Netter Australia 27 1.0k 765 652 366 352 89 2.1k
D W McCourt United States 28 894 0.9× 1.1k 1.4× 1.2k 1.8× 583 1.6× 537 1.5× 41 3.4k
D R Averett United States 30 1.5k 1.5× 1.0k 1.4× 735 1.1× 388 1.1× 888 2.5× 56 2.8k
Soon B. Hwang South Korea 28 1.4k 1.4× 1.8k 2.4× 970 1.5× 499 1.4× 289 0.8× 81 2.9k
Stephen Griffin United Kingdom 29 1.3k 1.3× 1.2k 1.6× 786 1.2× 281 0.8× 504 1.4× 54 2.6k
Takasuke Fukuhara Japan 25 896 0.9× 1.1k 1.5× 636 1.0× 348 1.0× 399 1.1× 123 2.6k
Roland Montserret France 27 1.2k 1.2× 1.5k 1.9× 834 1.3× 159 0.4× 342 1.0× 53 2.7k
Ray Sánchez-Pescador United States 27 1.1k 1.1× 757 1.0× 1.7k 2.6× 519 1.4× 576 1.6× 33 4.4k
Takayuki Hishiki Japan 23 1.0k 1.0× 1.1k 1.4× 844 1.3× 620 1.7× 441 1.3× 44 2.6k
Jan Mous Switzerland 29 814 0.8× 912 1.2× 1.4k 2.2× 404 1.1× 1.3k 3.6× 66 3.6k
Ľubica Supeková United States 20 781 0.8× 835 1.1× 1.1k 1.7× 363 1.0× 157 0.4× 28 2.4k

Countries citing papers authored by Hans Netter

Since Specialization
Citations

This map shows the geographic impact of Hans Netter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Netter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Netter more than expected).

Fields of papers citing papers by Hans Netter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Netter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Netter. The network helps show where Hans Netter may publish in the future.

Co-authorship network of co-authors of Hans Netter

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Netter. A scholar is included among the top collaborators of Hans Netter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Netter. Hans Netter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fareh, Mohamed, Wenxin Hu, Vitina Sozzi, et al.. (2024). CRISPR-Cas13b-mediated suppression of HBV replication and protein expression. Journal of Hepatology. 81(5). 794–805. 8 indexed citations
2.
Walsh, Renae, R. Hammond, Carina C. D. Joe, et al.. (2023). Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector. Viruses. 15(2). 313–313. 2 indexed citations
3.
Clark, Michelle P., Shringar Rao, Liana Mackiewicz, et al.. (2021). Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models. Cell Death and Disease. 12(7). 641–641. 8 indexed citations
4.
Joe, Carina C. D., Sayantani Chatterjee, George O. Lovrecz, et al.. (2020). Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity. Vaccine. 38(22). 3892–3901. 29 indexed citations
5.
Rawlinson, Stephen M., Christina L. Rootes, Paul J. McMillan, et al.. (2018). Viral regulation of host cell biology by hijacking of the nucleolar DNA-damage response. Nature Communications. 9(1). 3057–3057. 38 indexed citations
6.
Haqshenas, Gholamreza, Jianmin Wu, Kaylene J. Simpson, et al.. (2017). Signalome-wide assessment of host cell response to hepatitis C virus. Nature Communications. 8(1). 15158–15158. 12 indexed citations
7.
Yuen, Lilly, et al.. (2011). Modulation of the immunogenicity of virus-like particles composed of mutant hepatitis B virus envelope subunits. Antiviral Research. 93(2). 209–218. 11 indexed citations
8.
Chang, Shau‐Feng, et al.. (2004). Characterization of nonconventional hepatitis B viruses lacking the core promoter. Virology. 330(2). 437–446. 2 indexed citations
9.
Netter, Hans, Wai-Ping Woo, Robert W. Tindle, Roderick I. Macfarlan, & Eric J. Gowans. (2003). Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine. Vaccine. 21(21-22). 2692–2697. 22 indexed citations
10.
Pult, Irmgard, Hans Netter, Michael Brüns, et al.. (2001). Identification and Analysis of a New Hepadnavirus in White Storks. Virology. 289(1). 114–128. 39 indexed citations
12.
13.
Wu, Ting-Ting, Hans Netter, V. Bichko, David W. Lazinski, & John M. Taylor. (1994). RNA editing in the replication cycle of human hepatitis delta virus. Biochimie. 76(12). 1205–1208. 2 indexed citations
14.
Szostecki, Carin, Hans Will, Hans Netter, & Hans H. Guldner. (1992). Autoantibodies to the Nuclear Sp100 Protein in Primary Biliary Cirrhosis and Associated Diseases: Epitope Specificity and Immunoglobulin Class Distribution. Scandinavian Journal of Immunology. 36(4). 555–564. 48 indexed citations
15.
Netter, Hans, Hans Will, Carin Szostecki, & Hans H. Guldner. (1991). Repetitive p68-autoantigen specific epitopes recognized by human anti-(U1) small nuclear ribonucleoprotein autoantibodies. Journal of Autoimmunity. 4(4). 651–663. 12 indexed citations
16.
Guldner, Hans H., Hans Netter, Carin Szostecki, E Jaeger, & Hans Will. (1990). Human anti-p68 autoantibodies recognize a common epitope of U1 RNA containing small nuclear ribonucleoprotein and influenza B virus.. The Journal of Experimental Medicine. 171(3). 819–829. 52 indexed citations
17.
Guldner, Hans H., Hans Netter, Carin Szostecki, H.‐J. Lakomek, & Hans Will. (1988). Epitope mapping with a recombinant human 68-kDa (U1) ribonucleoprotein antigen reveals heterogeneous autoantibody profiles in human autoimmune sera.. The Journal of Immunology. 141(2). 469–475. 70 indexed citations
18.
Netter, Hans, et al.. (1988). A recombinant autoantigen derived from the human (u1) small nuclear rnp‐specific 68‐kd protein. Arthritis & Rheumatism. 31(5). 616–622. 33 indexed citations
19.
Netter, Hans. (1959). Theoretische Biochemie : physikalisch-chemische Grundlagen der Lebensvorgänge. Springer eBooks. 23 indexed citations
20.
Netter, Hans, et al.. (1952). [Theory of the potassium threshold in the muscle].. PubMed. 323(1). 53–66. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026